0
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
The Investments Portal The Investments Portal
The Investments Portal The Investments Portal
The Investments Portal The Investments Portal
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
The Investments Portal The Investments Portal
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
The Investments Portal > Investing > RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0 Shares
Share on Facebook Share on Twitter Share on Pinterest Share on Email
admin June 4, 2025
Previous Article 5 Biggest Blockchain ETFs in 2025
Next Article S&P 500 Bullish Patterns: Are Higher Highs Ahead?

You Might Also Enjoy

Prismo Metals Closes Strategic Transaction with Blade Resources

March 6, 2026
READ MORE

Oreterra Metals

March 6, 2026
READ MORE

Oreterra Metals: Close on the Trail of a Potentially Major New BC Copper-Gold Discovery

March 6, 2026
READ MORE

WPIC: Platinum Market Heading for Fourth Straight Deficit in 2026

March 6, 2026
READ MORE

      Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


      By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.


      • About us
      • Contact us
      • Privacy Policy
      • Terms & Conditions

      Copyright © 2026 TheInvestmentsPortal.com. All Rights Reserved.

      Our website uses cookies to improve your experience. Learn more about: Cookie Policy

      Accept